載入...
Effect of Alirocumab on Coronary Calcification in Patients With Coronary Artery Disease
BackgroundProprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors have been documented with significantly reduction in LDL cholesterol levels and cardiovascular events. However, evidence regarding the impact of PCSK9 inhibitors on coronary calcification is limited.MethodsEligible patients w...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2022-05-01
|
| 叢編: | Frontiers in Cardiovascular Medicine |
| 主題: | |
| 在線閱讀: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.907662/full |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|